• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.22% Nasdaq Up 0.20%

    Gilead Sciences, Inc. (GILD)

    -NasdaqGS
    67.50 Down 0.01(0.01%) Mar 27, 4:00PM EDT
    |After Hours : 67.50 0.00 (0.00%) Mar 27, 7:39PM EDT
    Prev Close:67.51
    Open:67.11
    Bid:67.50 x 1000
    Ask:68.50 x 100
    1y Target Est:79.10
    Beta:0.984203
    Earnings Date:Apr 26 - May 1 (Est.)
    Day's Range:66.97 - 67.82
    52wk Range:65.38 - 103.10
    Volume:5,455,289
    Avg Vol (3m):10,577,500
    Market Cap:88.23B
    P/E (ttm):6.79
    EPS (ttm):9.94
    Div & Yield:2.08 (3.08%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.01%88.23B
    GSKUp 0.90%102.96B
    PFEUp 0.53%203.55B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):8.95
    P/S (ttm):2.90
    Ex-Dividend Date:14-Mar-17

    Analysts

    Annual EPS Est (Dec-17) :8.24
    Quarterly EPS Est (Mar-17) :2.26
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-1.73

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in Europe, North America, Asia, South America, Africa, Australia, India, and the Middle East. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback